Skip to content

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

The NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study was a nationwide public health-focused clinical trial that compared the effectiveness of older (first available in the 1950s) and newer (available since the 1990s) antipsychotic medications used to treat schizophrenia. This page provides information about the study.

Questions and Answers

News about the CATIE Study

  • Press Release (July 2, 2008): Violence in Schizophrenia Patients More Likely Among Those with Childhood Conduct Problems
  • Press Release (March 1, 2007): New Details in Schizophrenia Treatment Trial Emerge
  • Press Release (Dec. 1, 2006): Older Medication May Be More Cost-Effective for Some Patients with Schizophrenia
  • Press Release (Sept. 19, 2005): NIMH Study To Guide Treatment Choices for Schizophrenia (Phase 1 Results)

Related Information